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INTRODUCTION
Continuity of care is a core value in general 
practice. It is a multifaceted concept, but one 
key aspect valued by patients is continuity of 
doctor; being able to see the same GP over 
time for multiple problems.1 In the UK, a 
combination of changes in the way primary 
care services are organised and doctors 
work means that patient–doctor continuity 
has been eroded.2 Seeing the same doctor 
is associated with higher patient satisfaction 
but evidence that it makes a difference to 
patient outcomes is weak.3,4
The value of being able to see the 
same doctor appears to depend on the 
nature of the problem.5 From the doctor’s 
perspective, familiarity with the patient may 
be especially helpful when dealing with 
new or ‘unspecified’ symptoms, such as 
fatigue.6 This may be particularly relevant 
to the diagnosis of cancers in primary care, 
where in the initial stages of the disease 
symptoms may be very non-specific and/
or may be explained by coexisting physical 
or psychological conditions. Conversely, it 
is possible that familiarity with the patient 
and their problems may mean doctors 
misattribute new complaints to ongoing 
problems or personality traits, leading to 
delayed or missed diagnoses.5,7
Surprisingly, there is little research 
published on the influence of patient–
doctor continuity on the diagnostic process 
in primary care, and even less in the field 
of cancer diagnostics.4 Therefore, this 
study investigated the relationship between 
patient–doctor continuity in general practice 
and time to diagnosis of lung, colorectal, 
and breast cancer in adults.
METHOD
Study data
Data were used from the General Practice 
Research Database, now known as the 
Clinical Practice Research Datalink, from 
1 January 2000 to 31 December 2009 
inclusive. General practices contribute to 
the database from around the UK and 
adhere to stringent data quality recording 
standards.8
Patients had an incident breast, 
colorectal, or lung cancer; were ≥40 years 
at diagnosis; and had ≥1 year of prior 
registration data. These cancers were 
chosen because they are common and GP 
personal knowledge of the patient may be 
more (for example, fatigue in colorectal or 
lung cancer) or less useful (for example, 
breast cancer, most commonly presenting 
with a breast lump). Patients were excluded 
if they had an in-situ cancer, their recorded 
date of death was before or the same as their 
diagnosis date, or they were asymptomatic 
(no recorded cancer symptom/sign) in 
the 12 months before diagnosis. Analyses 
were further restricted to consultations 
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Abstract
Background 
Continuity of care may affect the diagnostic 
process in cancer but there is little research.
Aim
To estimate associations between patient–
doctor continuity and time to diagnosis and 
referral of three common cancers. 
Design and setting
Retrospective cohort study in general practices 
in England. 
Method
This study used data from the General 
Practice Research Database for patients 
aged ≥40 years with a diagnosis of breast, 
colorectal, or lung cancer. Relevant cancer 
symptoms or signs were identified up to 
12 months before diagnosis. Patient–doctor 
continuity (fraction-of-care index adjusted for 
number of consultations) was calculated up to 
24 months before diagnosis. Time ratios (TRs) 
were estimated using accelerated failure time 
regression models.
Results
Patient–doctor continuity in the 24 months 
before diagnosis was associated with a slightly 
later diagnosis of colorectal (time ratio [TR] 
1.01, 95% confidence interval [CI] =1.01 to1.02) 
but not breast (TR = 1.00, 0.99 to 1.01) or lung 
cancer (TR = 1.00, 0.99 to 1.00). Secondary 
analyses suggested that for colorectal and 
lung cancer, continuity of doctor before the 
index consultation was associated with a 
later diagnosis but continuity after the index 
consultation was associated with an earlier 
diagnosis, with no such effects for breast 
cancer. For all three cancers, most of the delay 
to diagnosis occurred after referral. 
Conclusion
Any effect for patient–doctor continuity appears 
to be small. Future studies should compare 
investigations, referrals, and diagnoses in 
patients with and without cancer who present 
with possible cancer symptoms or signs; and 
focus on ‘difficult to diagnose’ types of cancer.
Keywords
cancer; continuity of care; diagnosis; general 
practice; patient–doctor continuity; symptoms.
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where symptoms or signs were recorded in 
consultations with GPs (partner, salaried, 
registrar, or locum) in relevant types of 
encounter (mainly surgery, telephone, or 
home visit). The few male patients in the 
breast cancer dataset were also excluded.
Relevant symptoms and signs (classified 
as high-risk or low-risk) for each cancer 
(Table 1) were based on the National 
Institute for Health and Care Excellence 
Referral Guidelines for Suspected Cancer.9 
These were updated by reference to recent 
systematic reviews on colorectal cancer10 
and breast cancer;11 and a case–control 
study of lung cancer.12 Symptoms and signs 
were identified using Read Codes only, 
which were independently identified and 
agreed by the GPs on the team. High-risk 
took precedence over low-risk symptoms 
or signs where both were recorded 
in the index consultation. The presence 
or absence of risk factors for each type 
of cancer were also identified: family 
history (breast cancer); ulcerative colitis 
(colorectal cancer); and current/ex-smoker 
or chronic obstructive pulmonary disease 
(lung cancer). Referrals, appropriate to 
each cancer, were identified for ‘definitive’ 
investigations (for example colonoscopy 
for colorectal cancer) or secondary care 
opinion (for example respiratory physician 
for lung cancer).
The list of diagnostic codes used has 
been developed previously as part of 
DISCOVERY (http://discovery-programme.
org/; a 5-year programme of work designed 
to improve the diagnosis of cancer) and has 
supported several publications.13–18 Patient 
multimorbidity was quantified by a simple 
count of 17 chronic diseases included 
in the clinical domain of the Quality and 
Outcomes Framework, as at 2007–2008, 
using methods described previously.19
Patient–doctor continuity
The index consultation (and hence the index 
doctor) was defined as the first consultation 
in the 12 months before diagnosis when 
a relevant cancer symptom or sign was 
recorded by a GP. Patients needed at least 
one other contact with the index GP in the 
24 months before diagnosis to be included 
in the study.
Patient–doctor continuity was 
summarised using the fraction-of-care (f  ) 
index, which is the proportion of doctor 
encounters during a continuity defining 
period that were made to the current 
provider (that is, the index GP). Because 
f is sensitive to utilisation levels (that 
is, people who visit infrequently), it was 
adjusted for the number of consultations in 
all analyses (f’ ). In the statistical models, f’ 
was multiplied by 10 so that the regression 
coefficients represent the change in 
outcome associated with a 10% difference 
in continuity.
In the primary analysis the effect of 
patient–doctor continuity was explored 
during the whole 24 months before 
diagnosis. In secondary analyses, the 
intervals were examined separately before 
the index consultation and after the index 
consultation.
Outcomes
This study investigated the effect of patient–
doctor continuity on time to diagnosis and 
time to referral, expressed as the number 
of days from the first recorded sign or 
symptom of cancer until date of cancer 
diagnosis or date of referral.
How this fits in
Continuity of care is a core value in 
general practice yet, nowadays, patients 
are less likely to see the same doctor. It is 
unknown whether seeing the same doctor 
leads to a faster or slower diagnosis of 
cancer among patients who present with 
symptoms. Overall, this study found that 
any effect of patient–doctor continuity on 
time to diagnosis of breast, colorectal, or 
lung cancer was small. While GPs should 
be cautious not to dismiss potentially 
significant symptoms or signs among 
patients they know well, it may be prudent 
for doctors to personally follow-up patients 
with ‘low-risk but not no-risk’ symptoms.
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Table 1. High-risk and low-risk cancer symptoms/signs for breast, 
colorectal, and lung cancer
Cancer symptoms or signs
Risk type Breast Colorectal Lung
High-risk Breast lump
Nipple eczema
Nipple distortion
Nipple discharge (bloody)
Rectal bleeding
Change in bowel habit, looser 
  stools and/or increased stool 
  frequency
Abdominal or rectal mass
Haemoptysis
Stridor
Superior vena cava 
  obstruction
Low-risk Breast skin changes
Breast pain
Weight loss
Fatigue
Abdominal pain
Anorexia
Constipation
Diarrhoea
Chest pain
Shoulder pain
Dyspnoea
Hoarseness
Cough
Chest signs
Finger clubbing
Cervical or supraclavicular 
  lymphadenopathy
Fatigue
Weight loss
Time to diagnosis (or diagnostic interval) 
was chosen as the primary end-point 
because the date of diagnosis is usually 
easily determined; previous studies have 
shown an effect of organisational change 
(that is, introduction of ‘2-week wait’ system) 
on this interval;20 and it allows the findings 
to be easily compared with most other 
studies.21
Time to referral (to relevant secondary 
care specialty or for definitive investigation) 
was explored as a secondary end-point 
because events after the referral (which 
are within the control of secondary care 
rather than primary care) may cause delays 
between referral and diagnosis. Where 
referral was made on the same day as 
the index consultation (around one-third 
of patients), 1 day was added so that the 
statistical model could be fitted.
Analysis
All analyses were carried out using Stata 
(version 12). First, a simple descriptive 
analysis was undertaken to examine the 
characteristics of participating patients, 
doctors, and their practices; patient–doctor 
consultation rates; number and type of 
symptoms/signs at the index consultation; 
and patient–doctor continuity before and 
after the index consultation.
Next, regression models (accelerated- 
failure time) were constructed to examine 
univariable and multivariable associations 
between patient–doctor continuity and 
time to diagnosis and time to referral. 
The accelerated failure time model 
is a parametric model that provides an 
alternative to proportional hazards models 
commonly used in time-to-event analyses.22 
It allows the derivation of a time ratio, which 
is more readily interpretable than a ratio 
of two hazards generated by other survival 
analysis approaches: a time ratio >1 for 
the covariate implies that it prolongs the 
time to the event, while a time ratio <1 
indicates that an earlier event is more 
likely.23 Plots were constructed to check 
model assumptions. Log-normal, log-
logistic, generalised gamma, and Weibull 
distributions were used to represent the 
survival data. The Akaike information 
criterion measure of the goodness of fit of 
an estimated statistical model was used to 
select the best model.
Alternative models for time to referral 
and time to diagnosis, using the different 
continuity defining periods, were 
constructed. The following covariates 
were included in each model: patient age, 
sex, multimorbidity, and cancer-specific 
risk factor(s); index doctor sex and status; 
index consultation type; and number of 
symptoms/signs at index consultation. 
Interactions between patient–doctor 
continuity and symptom/sign type (high/
low risk) were added to the models, but 
none with a likelihood ratio test <0.05 
were found. The extent of clustering by 
practice was estimated and adjusted for as 
necessary in all models.
RESULTS
Characteristics of participants and 
patients’ consultations
Table 2 shows the initial and final number of 
patients (with a relevant cancer, symptoms/
signs in the 12 months prior to diagnosis, 
and qualifying consultations) analysed in 
each cancer dataset. The characteristics 
of participants and patients’ consultations 
are given in Table 3. With respect to cancer 
risk factors, 81 (2.7%) of patients with 
e307  British Journal of General Practice, May 2015
Table 2. Construction of cancer datasets for analysis
Patients in each cancer dataset, n (%)
Breast Colorectal Lung
Initial dataset (combined clinical and referral data) 11 251 (100.0) 17 390 (100.0) 17 097 (100.0)
Ineligible diagnoses
In-situ cancers 1080 (9.6) 1554 (8.9) 1213 (7.1)
Date of death recorded before diagnosis or on same day 35 (0.3) 51 (0.3) 108 (0.6)
Asymptomatic patients 7066 (62.8) 8071 (46.4) 7229 (42.3)
Ineligible consultations
No previous encounter with index GP 51 (0.5) 272 (1.6) 354 (2.1)
Index GP sex unknown 50 (0.4) 48 (0.3) 50 (0.3)
Patient malea 14 (0.1) n/a n/a
Patients included in analysis 2955 (26.3) 7394 (42.5) 8143 (47.6)
aBreast cancer analysis was restricted to female patients only. n/a = not applicable.
Table 3. Characteristics of participants and patients’ consultations
Patients in each cancer dataset, n (%)
Characteristic Breast Colorectal Lung
Practices, n 465 475 476
Doctors, n 1836 2564 2843
GP partners, n (%) 1635 (89.1) 2181 (85.1) 2412 (84.8)
Female, n (%) 971 (52.9) 1214 (47.3) 1425 (50.1)
Patients, n 2955 7394 8143
Mean age, years (SD) 66.7 (14.1) 71.4 (11.3) 71.5 (10.2)
Female, n (%) 2955 (100.0) 3442 (46.6) 3471 (42.6)
Mean multimorbidity score (SD) 1.2 (1.3) 1.3 (1.3) 1.3 (1.3)
Patient–doctor consultationsa
Mean number (SD) 15.3 (13.7) 16.6 (13.1) 19.9 (14.3)
Continuity (f’ ) 0.58 (0.23) 0.62 (0.21) 0.66 (0.18)
Cancer symptoms/signs
Total 2989 7648 8531
Mean (SD) per patient 1.0 (0.1) 1.0 (0.2) 1.1 (0.2)
High risk
- No. (%) by symptom/sign total 2805 (93.8) 1507 (19.7) 647 (7.6)
- No. (%) by consultations 2797 (94.2) 2528 (34.2) 636 (7.8)
Median time to referral in days (IQR) 0 (0–0) 8 (0–51) 36 (7–117)
Median time to diagnosis in days (IQR) 23 (14–42) 80 (36–174) 104 (44–223)
aDuring 24 months before diagnosis. IQR =  interquartile range. f = fraction-of-care index.
breast cancer had a family history of breast 
cancer; 91 (1.2%) of patients with colorectal 
cancer had ulcerative colitis; and 1845 
(22.7%) of patients with lung cancer had a 
history of chronic obstructive pulmonary 
disease, with about one-third being current 
smokers (n = 2639, 32.4%) and one-half 
ex-smokers (n = 4079, 50.1%). 
Patients with breast cancer were more 
likely to present initially with at least one 
high-risk symptom or sign (n = 2797, 94.2%) 
than those with subsequent colorectal 
(n = 2528, 34.2%) or lung (n = 636, 7.8%) 
cancer diagnoses (Table 3); and (n = 2559, 
86.6%) of patients with breast cancer were 
referred on the same day as the index 
consultation.
Patient–doctor continuity and diagnosis 
of breast, colorectal, and lung cancer
The crude and adjusted associations 
with time to diagnosis for patient–doctor 
continuity, symptoms/signs and patient, 
doctor, and consultation characteristics 
for the three different cancers are shown 
in Table 4. There was no evidence of 
any association between patient–doctor 
continuity and time to diagnosis for breast 
cancer (adjusted TRbreast = 1.00, 95% 
CI = 0.99 to 1.01, P = 0.90) or lung cancer 
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Table 4. Crude and adjusted associations between patient–doctor continuity and time to diagnosis of 
breast, colorectal, and lung cancer
Breast Colorectal Lung
Covariate
Crude 
time ratio   
(95% CI) P-value
Adjusted 
time ratio 
(95% CI) P-value
Crude 
time ratio 
(95% CI) P-value
Adjusted 
time ratio 
(95% CI) P-value
Crude time 
ratio (95% 
CI) P-value
Adjusted 
time ratio 
(95% CI) P-value
Patient–doctor 
continuitya
1.01 
(1.00 to 1.02)
0.28 1.00  
(0.99 to 1.01)
0.90 1.00 
(0.99 to 1.00)
0.21 1.01 
(1.01 to 1.02)
<0.01 0.98 
(0.98 to 0.99)
<0.01 1.00 
(0.99 to 1.00)
0.33
Number of 
consultations
1.00 
(1.00 to 1.00)
0.67 1.00 
(1.00 to 1.00)
0.07 1.02 
(1.02 to 1.02)
<0.01 1.02 
(1.01 to 1.02)
<0.01 1.01 
(1.01 to 1.02)
<0.01 1.01 
(1.01 to 1.01)
<0.01
Patient
Age 0.99 
(0.99 to 0.99)
<0.01 0.99 
(0.99 to 1.00)
<0.01 1.00 
(1.00 to 1.00)
<0.01 1.00 
(1.00 to 1.00)
<0.01 1.00 
(1.00 to 1.00)
<0.01 1.00 
(1.00 to 1.00)
0.20
Female n/a n/a 1.08 
(1.04 to 1.13)
<0.01 1.05 
(1.01 to 1.09)
0.03 1.06 
(1.02 to 1.10)
<0.01 1.03 
(0.99 to 1.07)
0.12
Multimorbidity 0.95 
(0.93 to 0.97)
<0.01 0.97 
(0.95 to 1.00
0.04 1.06 
(1.04 to 1.08)
<0.01 0.99 
(0.98 to 1.01)
0.48 1.06 
(1.05 to 1.08)
<0.01 1.02 
(1.01 to 1.04)
<0.01
Risk factorb 0.96 
(0.79 to 1.15)
0.64 0.92 
(0.77 to 1.10)
0.35 1.22 
(1.02 to 1.47)
0.03 1.15 
(0.96 to 1.37)
0.13 1.30 
(1.24 to 1.35)
<0.01 1.19 
(1.14 to 1.24)
<0.01
Current smoker n/a n/a n/a n/a 0.95 
(0.92 to 0.99)
0.02 0.90 
(0.85 to 0.95)
<0.01
Ex-smoker n/a n/a n/a n/a 1.03 
(0.99 to 1.07)
0.13 0.91 
(0.86 to 0.95)
<0.01
Index doctor
Female 0.92 
(0.87 to 0.98)
0.01 0.92 
(0.86 to 0.98)
0.01 1.02 
(0.98 to 1.07)
0.25 1.03 
(0.99 to 1.08)
0.15 1.02 
(0.99 to 1.07)
0.17 1.00 
(0.96 to 1.04)
0.96
Status 
 Salaried 0.92 
(0.68 to 1.25)
0.59
0.91 
(0.67 to 1.23)
0.46
0.94 
(0.74 to 1.19)
0.72
0.86 
(0.68 to 1.09)
0.45
0.99 
(0.80 to 1.24)
0.08
1.02 
(0.82 to 1.27)
0.15
 Locum 1.05 
(0.93 to 1.20)
1.07 
(0.94 to 1.21)
0.97 
(0.89 to 1.06)
1.00 
(0.92 to 1.10)
0.92 
(0.85 to 0.99)
0.93 
(0.86 to 1.00)
Consultation type 
Surgery 1.14 
(1.02 to 1.29)
0.04
1.13 
(1.01 to 1.26)
0.16
1.00 
(0.91 to 1.08)
0.17
0.99 
(0.91 to 1.08)
0.19
1.07 
(0.98 to 1.16)
<0.01
1.08 
(0.99 to 1.17)
<0.01Telephone 1.24 
(0.94 to 1.63)
1.22 
(0.94 to 1.58)
1.11 
(0.98 to 1.27)
1.02 
(0.90 to 1.16)
1.09 
(0.97 to 1.24)
1.01 
(0.90 to 1.14)
Visit 0.99 
(0.82 to 1.20)
1.15 
(0.95 to 1.38)
0.98 
(0.88 to 1.10)
0.91 
(0.82 to 1.02)
0.96 
(0.86 to 1.06)
0.92 
(0.83 to 1.01)
Symptoms/signs
Number 1.38 
(0.94 to 2.01)
0.10 1.42 
(0.98 to 2.05)
0.06 0.89 
(0.81 to 0.98)
0.03 0.96 
(0.87 to 1.06)
0.44 0.99 
(0.91 to 1.07)
0.74 0.99 
(0.91 to 1.07)
0.75
High-risk 0.32 
(0.28 to 0.37)
<0.01 0.34 
(0.29 to 0.39)
<0.01 0.68 
(0.65 to 0.71)
<0.01 0.72 
(0.69 to 0.75)
<0.01 0.66 
(0.61 to 0.70)
<0.01 0.70 
(0.65 to 0.74)
<0.01
aModified fraction-of-care index (f’); continuity defining period before and after index consultation. bBreast cancer: family history of breast cancer; colorectal cancer: ulcerative colitis; 
lung cancer: chronic obstructive pulmonary disease. n/a = not applicable.
(adjusted TRlung = 1.00, 95% CI = 0.99 to 
1.00, P = 0.33). The adjusted TR of 1.01 (95% 
CI = 1.01 to 1.02, P<0.01) for colorectal 
cancer suggests there was a 1% increase in 
the diagnostic interval for every 10% increase 
in continuity. The factor most consistently 
associated with time to diagnosis across 
the different cancers was a high-risk 
symptom/sign being recorded at the index 
consultation (adjusted TRbreast = 0.34, 95% 
CI = 0.29 to 0.39, P<0.01; TRcolorectal = 0.72, 
95% CI = 0.69 to 0.75, P<0.01; TRlung = 0.70, 
95% CI = 0.65 to 0.74, P<0.01).
Further analysis examined whether 
there was a relationship between patient–
doctor continuity before or after the 
index consultation and time to diagnosis 
(Table 5). There was no evidence of an 
effect for patient–doctor continuity on time 
to diagnosis over any continuity-defining 
period for breast cancer. There was 
some evidence that increased continuity 
before the index consultation increased 
the time to diagnosis for both colorectal 
cancer (adjusted TRcolorectal = 1.02, 95% 
CI = 1.01 to 1.02, P<0.01) and lung cancer 
(TRlung = 1.01, 95% CI = 1.00 to 1.01, 
P<0.01). Conversely, there was evidence 
that seeing the same doctor after the index 
consultation reduced the delay to diagnosis 
(adjusted TRcolorectal = 0.98, 95% CI = 0.98 
to 0.99, P<0.01; TRlung = 0.98, 95% CI = 0.97 
to 0.98, P<0.01).
Finally, evidence of an effect for 
patient–doctor continuity before the index 
consultation on time to referral was 
found for patients with breast cancer only 
(adjusted TRbreast = 0.90, 95% CI = 0.85 to 
0.95, P<0.01) (Table 5).
DISCUSSION
Summary
Overall, patient–doctor continuity was not 
associated with clinically important changes 
in time to diagnosis for patients with breast, 
colorectal, or lung cancer. In the primary 
analyses, the association seen with later 
diagnosis of colorectal cancer equates to 
a maximum delay of around 7 days; while 
in the secondary analyses the maximum 
reduction in time to diagnosis for patients 
with colorectal or lung cancer who see the 
same doctor after the index consultation 
are up to 14 and 18 days, respectively. 
For all cancers, the most significant factor 
predicting earlier diagnosis was first 
presentation with a high-risk symptom or 
sign; and the greatest delay for diagnosis 
of all three cancers occurred after the 
patients had been referred.
Strengths and limitations
This is the first study to explore, using 
a large, reliable, and validated dataset, 
the effect of patient–doctor continuity on 
the diagnostic process of three common 
cancers (breast, colorectal, and lung). 
However, the analyses were restricted 
to between 26.3%, (n = 2955, breast), and 
47.6%, (n = 8143, lung) of the original 
datasets most patients were excluded 
because they had no relevant Read-Coded 
symptoms or signs in the 12 months before 
diagnosis. It is important to remember 
that the data for this study come from 
medical records whose primary purpose is 
clinical care, rather than research, so it is 
likely that relevant symptoms and signs in 
both included and excluded patients were 
not coded. In addition, the final route by 
which patients obtained their diagnoses 
is not known. A significant proportion of 
patients may have been diagnosed after 
being admitted through the emergency 
department, independent of their GP.24
This study highlights the methodological 
challenges of operationalising continuity 
in this type of research.25 It was decided 
to quantify continuity in relation to the 
doctor seen at the index consultation and, 
while other approaches are possible (for 
example, defining continuity in terms of 
‘usual doctor’), the authors believe this 
is the most appropriate for the research 
question posed: ‘Does seeing the same GP 
(around time of first presentation of possible 
cancer symptoms or signs) reduce time to 
diagnosis of three common cancers?’. A 
modified form of an established continuity 
index (fraction-of-care) was used but the 
findings were the same when the analyses 
were repeated using another more widely 
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Table 5. Adjusted associations between patient–doctor continuity for 
different continuity-defining periods and time to referral and time to 
diagnosis of breast, colorectal, and lung cancer
 Continuity-defining  Time ratios (95% CI)
Outcome perioda Breast cancer Colorectal cancer Lung cancer
Time to diagnosis Before and after 1.00 1.01 1.00 
 (primary analysis) (0.99 to 1.01) (1.01 to 1.02) (0.99 to 1.00) 
  P = 0.90 P<0.01 P = 0.33
 Before 1.00 1.02 1.01 
  (0.99 to 1.01) (1.01 to 1.02) (1.00 to 1.01) 
  P = 0.75 P<0.01 P<0.01
 After 0.99 0.98 0.98 
  (0.99 to 1.00) (0.98 to 0.99) (0.97 to 0.98) 
  P = 0.26 P<0.01 P<0.01
Time to referral Before 0.90 0.99 1.01 
  (0.85 to 0.95) (0.98 to 1.01) (0.99 to 1.03) 
  P<0.01 P = 0.44 P = 0.34
aIn relation to index consultation, up to 24 months pre-diagnosis.
used index (Continuity of Care; available 
from the authors on request).26
This study improves our understanding 
of the role of patient–doctor continuity in 
patients who present with symptoms and 
signs who are subsequently diagnosed with 
cancer but not those with other outcomes 
or diagnoses. Also, any association 
between patient–doctor continuity and 
earlier diagnosis will be affected by 
variation in individual doctors’ thresholds 
for investigating symptoms and making 
referrals. That is, if doctors who provide 
low continuity also have a high referral 
rate, their patients will have a short delay to 
diagnosis of cancer, but at the expense of a 
high number of referrals that do not lead to 
a cancer diagnosis.
Comparison with existing literature
Several studies have examined the role of 
continuity in relation to cancer screening27–30 
but the authors are aware of only two 
studies concerning diagnosis.31,32 Both were 
conducted in the US and neither found 
that continuity at a primary care level was 
associated with an earlier stage of cancer 
at diagnosis. The continuity literature 
provides reasons to support and explain the 
observation in this study that seeing a known 
doctor at first presentation appears to delay 
diagnosis, yet seeing the same doctor 
afterwards promotes earlier diagnosis. In 
the case of the former, familiarity with the 
patient and their problems may mean that 
doctors make assumptions and become 
closed to other diagnoses;33 the doctor may 
‘fail to see the wood for the trees’ and 
misattribute symptoms or dismiss them.5 
However, when seeing the same doctor 
afterwards, the doctor may assume greater 
responsibility for the patient in ensuring 
complaints are followed up and to ensure 
that symptoms are either explained or 
resolved.5 It is noteworthy that the mean 
number of consultations in the 12 months 
before diagnosis for each cancer is higher 
than might be expected for populations 
in these age groups,34 although there is a 
wide variation as reflected in the standard 
deviations. Consultation frequency itself 
may be a cause for concern in the pre-
diagnosis period.35
Implications for research and practice
Future studies should examine the value 
of patient–doctor continuity in relation 
to the investigations and referrals that 
doctors make for patients who present 
with possible cancer symptoms or signs 
who do and do not go on to be given a 
cancer diagnosis. Ideally, future research 
should be prospective and incorporate 
other important patient characteristics 
(disclosure of symptoms and signs) 
and doctor characteristics (tolerance of 
uncertainty and personal thresholds for 
organising investigations and referrals), so 
that the relationship between continuity 
and these other factors can be assessed 
comprehensively. Finally, it would be worth 
repeating this work in ‘hard to diagnose’ 
cancers, in particular, those which 
are associated with a larger number of 
consultations before referral.36,37
What should GPs and policy makers do 
meanwhile? In keeping with much of the 
continuity literature in relation to patient 
outcomes, this study does not provide 
strong evidence that patient–doctor 
continuity reduces the time to diagnosis 
of breast, colorectal, or lung cancer. 
Rather, it suggests that doctors working in 
primary care should be cautioned against 
overlooking potentially worrying symptoms 
or signs among patients who they know 
well. Previous work has highlighted the 
potential problems of ‘over-familiarity’ and 
the potential benefit of having a ‘fresh set of 
eyes’.5,38 However, that is not to negate the 
psychological benefits that some patients 
may derive from ‘following through’ a cancer 
diagnosis with the same GP. Until further 
work is carried out, it would seem sensible 
to recommend that practices encourage 
patients to follow new problems up with 
the same doctor, especially for patients 
whose symptoms or signs at the initial 
consultation may represent an underlying 
cancer but do not in themselves warrant 
immediate investigation or referral.
Finally, although much attention has 
been given to reducing delays to referral 
from general practice for patients with 
symptoms suggestive of cancer, these data 
suggest that more attention should be given 
to the process of care between referral 
and diagnosis. This is the main source of 
delay and where there is most scope for 
reductions in the time to diagnosis.
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